Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Expert Opinion on Drug Discovery|October 6, 2016
Recent advances in targeting the fatty acid biosynthetic pathway using fatty acid synthase inhibitorsThelma S Angeles, Robert L Hudkins
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Synthesis and kinase inhibitory activity of 3'-(S)-epi-K-252aDiane E Gingrich, Robert L Hudkins
Current Topics in Medicinal Chemistry|February 20, 2010
Histamine H3 antagonists for treatment of cognitive deficits in CNS diseasesRita Raddatz, Ming Tao, Robert L Hudkins
Current Drug Targets. CNS and Neurological Disorders|May 29, 2003
Targeting the JNK pathway for therapeutic benefit in CNS diseaseDonna Bozyczko-Coyne, Michael S Saporito, Robert L Hudkins
Progress in Medicinal Chemistry|January 9, 2003
Discovery of CEP-1347/KT-7515, an inhibitor of the JNK/SAPK pathway for the treatment of neurodegenerative diseasesMichael S Saporito, Robert L Hudkins, Anna C Maroney
Bioorganic & Medicinal Chemistry Letters|September 13, 2011
Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H₃ receptor antagonistsMing Tao, Rita Raddatz, Lisa D Aimone, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2005
Synthesis and structure-activity relationships of novel pyrrolocarbazole lactam analogs as potent and cell-permeable inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)Gregory J Wells, Ron Bihovsky, Robert L Hudkins, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2012
Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonistsKurt A Josef, Lisa D Aimone, Jacquelyn Lyons, et al.
ACS Chemical Neuroscience|January 24, 2012
Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug DiscoveryArup K Ghose, Torsten Herbertz, Robert L Hudkins, et al.
Pageof 5